Back
Inozyme Pharma Vs. Xeris Biopharma Holdings Industry Stock Comparison
Buy
62
INZY
Inozyme Pharma
Last Price:
4.64
Seasonality Move:
-8.94%
Buy
73
XERS
Xeris Biopharma Holdings
Last Price:
1.85
Seasonality Move:
-5.66%
Buy
62
Inozyme Pharma (INZY)
is a Buy
Is Inozyme Pharma a Buy, Sell or Hold?
- The current Inozyme Pharma [INZY] share price is $4.61. The Score for INZY is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- INZY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
73
Xeris Biopharma Holdings (XERS)
is a Buy
Is Xeris Biopharma Holdings a Buy, Sell or Hold?
- The current Xeris Biopharma Holdings [XERS] share price is $1.88. The Score for XERS is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
- XERS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
INZY Stock Price Chart
What is Inozyme Pharma's stock price today?
-
The Inozyme Pharma share price today is $4.61
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INZY is experiencing slight selling pressure.
XERS Stock Price Chart
What is Xeris Biopharma Holdings's stock price today?
-
The Xeris Biopharma Holdings share price today is $1.88
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XERS is experiencing slight selling pressure.
INZY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.3 | Sell |
| Relative Strength Index (14 RSI): | 40.68 | Sell |
| Chaikin Money Flow: | -248069 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.25 - 5.73) | Sell |
| Bollinger Bands (100): | (4.34 - 6.14) | Sell |
XERS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.07 | Sell |
| Relative Strength Index (14 RSI): | 46.49 | Sell |
| Chaikin Money Flow: | -96727 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.74 - 1.98) | Buy |
| Bollinger Bands (100): | (1.91 - 2.77) | Sell |
INZY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.6 | Buy |
| 20-day SMA: | 4.66 | Sell |
| 50-day SMA: | 5.65 | Sell |
| 200-day SMA: | 4.67 | Sell |
| 8-day EMA: | 4.65 | Sell |
| 20-day EMA: | 4.85 | Sell |
| 50-day EMA: | 5.22 | Sell |
| 200-day EMA: | 4.91 | Sell |
XERS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.82 | Buy |
| 20-day SMA: | 1.82 | Buy |
| 50-day SMA: | 2.13 | Sell |
| 200-day SMA: | 2.17 | Sell |
| 8-day EMA: | 1.84 | Buy |
| 20-day EMA: | 1.87 | Buy |
| 50-day EMA: | 2.06 | Sell |
| 200-day EMA: | 2.17 | Sell |
Inozyme Pharma Earnings Growth & INZY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.17 per share, and an increase next year of $0.07 per share.
Xeris Biopharma Holdings Earnings Growth & XERS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and an increase next year of $0.20 per share.
Inozyme Pharma Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Xeris Biopharma Holdings Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||